What's Happening?
In 2026, a new rule by the Centers for Medicare & Medicaid Services (CMS) has been implemented to address the issue of insurance denials for medical scans, such as PET scans. The rule, CMS-0057-F, mandates that insurers must respond to standard prior
authorization requests within seven calendar days and urgent requests within 72 hours, a reduction from the previous 14-day period. This change comes in response to widespread frustration among patients, including celebrities like Christy Carlson Romano, who have faced denials for necessary medical scans. Romano, known for her roles in 'Even Stevens' and 'Kim Possible,' shared her experience of having a cancer screening denied by her insurer, highlighting a common issue where insurers deny coverage based on criteria such as lack of prior authorization or medical necessity. The cost of PET scans can range from $1,500 to $6,000, making denials a significant financial burden for patients.
Why It's Important?
The CMS rule change is significant as it aims to streamline the prior authorization process, reducing the time patients must wait for insurance decisions on critical medical scans. This is particularly important for patients requiring timely diagnostics for conditions like cancer. The rule also requires Medicare Advantage, Medicaid, and ACA marketplace insurers to publicly disclose their prior authorization approval and denial rates, providing transparency and allowing consumers to make informed choices about their insurance plans. This transparency could lead to increased competition among insurers to improve their approval rates, ultimately benefiting patients. The ability to appeal denials and the requirement for insurers to adhere to stricter timelines could reduce the financial and emotional stress on patients, ensuring they receive necessary medical care without undue delay.
What's Next?
Patients who face denials can now utilize a more structured appeal process. They have 180 days from the denial notice to file an internal appeal, and if unsuccessful, they can request an external review. The new rules empower patients to challenge denials more effectively, with nearly half of external reviews overturning initial denials. Insurers may need to adjust their processes to comply with the new timelines and transparency requirements, potentially leading to operational changes within the industry. Patients are encouraged to familiarize themselves with the appeal process and utilize resources such as state insurance departments if they encounter issues. The increased transparency and accountability could lead to broader reforms in how insurers handle prior authorizations, potentially influencing policy changes at both state and federal levels.
